SK bioscience Co.,Ltd.
KRX:302440.KS
53800 (KRW) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 61,648 | 26,777.434 | 22,270.678 | 90,604.217 | 231,826.284 | 26,478.227 | 20,596.828 | 140,300.831 | 91,052.875 | 138,280.832 | 87,091.333 | 450,857.868 | 220,828.833 | 144,604.268 | 112,709.961 | 67,008.976 | 98,689.076 | 39,420.937 | 22,661.912 | 55,595.342 | 50,472.966 | 51,158.525 | 26,710.869 | 40,304.95 | 47,868.638 |
| Cost of Revenue
| 0 | 10,389.504 | 18,560.536 | 62,920.483 | 126,344.487 | 19,997.495 | 19,711.707 | 91,521.746 | 35,264.073 | 52,135.306 | 39,283.159 | 168,368.002 | 89,476.203 | 61,566.071 | 39,307.527 | 36,292.959 | 46,994.915 | 30,836.285 | 16,144.558 | 34,898.248 | 29,022.387 | 20,181.801 | 21,975.569 | 22,770.892 | 26,187.177 |
| Gross Profit
| 61,648 | 16,387.93 | 3,710.142 | 27,683.734 | 105,481.797 | 6,480.732 | 885.121 | 48,779.085 | 55,788.802 | 86,145.526 | 47,808.174 | 282,489.866 | 131,352.63 | 83,038.197 | 73,402.434 | 30,716.017 | 51,694.161 | 8,584.653 | 6,517.354 | 20,697.095 | 21,450.579 | 30,976.723 | 4,735.3 | 17,534.058 | 21,681.461 |
| Gross Profit Ratio
| 1 | 0.612 | 0.167 | 0.306 | 0.455 | 0.245 | 0.043 | 0.348 | 0.613 | 0.623 | 0.549 | 0.627 | 0.595 | 0.574 | 0.651 | 0.458 | 0.524 | 0.218 | 0.288 | 0.372 | 0.425 | 0.606 | 0.177 | 0.435 | 0.453 |
| Reseach & Development Expenses
| 0 | 29,806.76 | 24,473.24 | 21,122.359 | 24,879.749 | 26,246.039 | 16,139.693 | 24,332.528 | 17,441.753 | 11,074.958 | 12,319.08 | 14,784.873 | 15,623.933 | 7,690.365 | 9,150.904 | 9,925.808 | 6,508.412 | 0 | 4,543.743 | 8,165.91 | 5,445.334 | 0 | 5,560.379 | 7,137.442 | 3,374.969 |
| General & Administrative Expenses
| 0 | 1,417.055 | 33,498.235 | 2,012.199 | 44,544.432 | 1,660.269 | 30,073.927 | 0 | 1,497.582 | 1,303.55 | 1,097.965 | 1,225.496 | 1,125.332 | 1,120.406 | 696.129 | 818.578 | 472.962 | 11,675.256 | 572.263 | 621.513 | 546.696 | 14,283.125 | 603.782 | 580.086 | 543.113 |
| Selling & Marketing Expenses
| 0 | 4,047.197 | -19,149.014 | 6,133.576 | 4,866.343 | 4,189.833 | 3,193.144 | 0 | 5,538.03 | 4,032.255 | 3,124.707 | 3,885.957 | 2,839.533 | 2,518.881 | 2,327.355 | 4,124.018 | 2,318.031 | 0 | 1,830.312 | 3,441.633 | 2,878.353 | 0 | 2,357.9 | 3,462.33 | 2,451.871 |
| SG&A
| 0 | 14,151.678 | 14,349.221 | 17,198.093 | 44,544.432 | 5,850.102 | 30,073.927 | 22,805.821 | 7,035.612 | 5,335.805 | 4,222.672 | 5,111.453 | 3,964.865 | 3,639.287 | 3,023.484 | 4,942.596 | 2,790.993 | 11,675.256 | 2,402.575 | 4,063.146 | 3,425.049 | 14,283.125 | 2,961.682 | 4,042.416 | 2,994.984 |
| Other Expenses
| -101,262 | -502.217 | -188.659 | -435.018 | -89,088.864 | -796.997 | -16,139.693 | -136.259 | 9,952.624 | 8,545.092 | 7,514.439 | 1,275.839 | 859.637 | 1,741.43 | 916.119 | 647.901 | 2,222.298 | 686.768 | -476.363 | -406.559 | -2.572 | 44.831 | 53.238 | -532.875 | 52.069 |
| Operating Expenses
| 101,262 | 44,460.655 | 39,011.12 | 38,755.47 | -44,544.432 | 41,789.743 | 30,073.927 | 47,274.608 | 34,429.989 | 24,955.855 | 24,056.191 | 28,546.056 | 30,946.399 | 16,883.602 | 19,687.213 | 19,804.246 | 15,220.584 | 11,675.256 | 10,931.536 | 15,691.363 | 12,482.983 | 14,283.125 | 12,605.705 | 13,731.325 | 10,277.537 |
| Operating Income
| -39,614 | -28,072.725 | -35,300.978 | -11,071.736 | 60,937.365 | -35,309.011 | -29,188.807 | 1,504.477 | 40,490.284 | 61,189.671 | 23,751.983 | 253,943.811 | 100,406.231 | 66,154.594 | 53,715.221 | 10,911.772 | 36,473.577 | -3,090.603 | -4,414.182 | 5,005.732 | 8,967.596 | 16,693.598 | -7,870.407 | 3,802.734 | 11,403.924 |
| Operating Income Ratio
| -0.643 | -1.048 | -1.585 | -0.122 | 0.263 | -1.334 | -1.417 | 0.011 | 0.445 | 0.443 | 0.273 | 0.563 | 0.455 | 0.457 | 0.477 | 0.163 | 0.37 | -0.078 | -0.195 | 0.09 | 0.178 | 0.326 | -0.295 | 0.094 | 0.238 |
| Total Other Income Expenses Net
| 8,957 | 11,171.641 | 15,495.367 | 14,676.655 | -2,314.715 | 6,074.11 | 3,523.367 | 28,952.657 | -17,314.27 | -5,846.619 | 9,005 | -766.445 | -3,833.823 | 1,737.057 | 1,326.884 | -283.463 | 1,531.718 | -240.675 | -1,424.773 | -2,095.564 | -575.979 | -693.495 | -946.21 | -13,521.382 | -821.285 |
| Income Before Tax
| -30,657 | -16,901.084 | -19,805.611 | 3,604.918 | 58,622.65 | -29,234.901 | -25,665.44 | 30,457.133 | 23,176.014 | 55,343.052 | 32,756.983 | 251,622.016 | 96,572.408 | 67,891.652 | 55,042.104 | 10,628.308 | 38,005.295 | -3,331.279 | -5,838.955 | 2,910.168 | 8,391.617 | 16,000.103 | -8,816.615 | -9,718.649 | 10,582.639 |
| Income Before Tax Ratio
| -0.497 | -0.631 | -0.889 | 0.04 | 0.253 | -1.104 | -1.246 | 0.217 | 0.255 | 0.4 | 0.376 | 0.558 | 0.437 | 0.469 | 0.488 | 0.159 | 0.385 | -0.085 | -0.258 | 0.052 | 0.166 | 0.313 | -0.33 | -0.241 | 0.221 |
| Income Tax Expense
| -8,340 | -5,492.189 | -6,087.616 | -564.692 | 10,230.689 | -13,258.905 | -11,397.584 | 2,715.57 | 2,397.885 | 9,217.11 | 4,950.668 | 67,656.485 | 20,135.107 | 15,079.873 | 13,117.439 | 750.024 | 5,797.481 | -803.605 | -815.191 | -841.446 | 3,163.489 | 2,048.485 | -562.661 | -2,256.757 | 2,699.903 |
| Net Income
| -22,317 | -11,408.895 | -13,717.995 | 4,169.611 | 48,391.961 | -15,975.996 | -14,267.856 | 27,741.563 | 20,778.129 | 46,125.942 | 27,806.315 | 183,965.531 | 76,437.301 | 52,811.78 | 41,924.665 | 9,878.284 | 32,207.814 | -2,527.673 | -5,023.764 | 3,751.613 | 5,228.128 | 13,951.618 | -8,253.955 | -7,461.891 | 7,882.736 |
| Net Income Ratio
| -0.362 | -0.426 | -0.616 | 0.046 | 0.209 | -0.603 | -0.693 | 0.198 | 0.228 | 0.334 | 0.319 | 0.408 | 0.346 | 0.365 | 0.372 | 0.147 | 0.326 | -0.064 | -0.222 | 0.067 | 0.104 | 0.273 | -0.309 | -0.185 | 0.165 |
| EPS
| -290.48 | -148.5 | -178.56 | 54.3 | 630.23 | -208.06 | -185.82 | 361.29 | 271 | 601 | 363 | 2,447.67 | 1,017 | 693 | 659 | 1,614.19 | 526 | -40.74 | -82.49 | 1,839.16 | 475 | 6,839 | -4,046 | -3,730.6 | 3,941 |
| EPS Diluted
| -290.48 | -148.5 | -178.12 | 54.14 | 630.23 | -208.06 | -185.26 | 360.19 | 270 | 598 | 361.04 | 2,447.67 | 1,010 | 688 | 654 | 1,614.19 | 526 | -40.74 | -82.49 | 1,839.16 | 475 | 6,839 | -4,046 | -3,730.6 | 3,941 |
| EBITDA
| -39,614 | -18,998.346 | -26,171.791 | -1,975.351 | 105,481.797 | -20,468.507 | 885.121 | 9,353.17 | 47,637.182 | 81,308.589 | 33,482.554 | 261,844.035 | 105,534.694 | 72,489.102 | 57,774.624 | 20,104.084 | 44,297.272 | 1,016.413 | -3,997.978 | 10,212.748 | 10,459.511 | 20,314.762 | -5,065.096 | 5,973.534 | 12,314.685 |
| EBITDA Ratio
| -0.643 | -0.709 | -1.175 | -0.022 | 0.455 | -0.773 | 0.043 | 0.067 | 0.523 | 0.588 | 0.384 | 0.581 | 0.478 | 0.501 | 0.513 | 0.3 | 0.449 | 0.026 | -0.176 | 0.184 | 0.207 | 0.397 | -0.19 | 0.148 | 0.257 |